Amylyx Pharmaceuticals, Inc. Ttl Offering Amt
Financial Statements › Notes
ffd:TtlOfferingAmt · last filed 2026-08-20
- 2026-08-20: Ttl Offering Amt $575.22M.
| Period end | Ttl Offering Amt |
|---|---|
| 2026-08-20 | $575.22M 424B5 · filed 2026-08-20 |
Financial Statements › Notes
ffd:TtlOfferingAmt · last filed 2026-08-20
| Period end | Ttl Offering Amt |
|---|---|
| 2026-08-20 | $575.22M 424B5 · filed 2026-08-20 |